These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6987595)

  • 21. [Bone marrow grafts].
    Gluckman E
    Rev Prat; 1980 Mar; 30(13):813-4, 817-8, 821. PubMed ID: 6990459
    [No Abstract]   [Full Text] [Related]  

  • 22. Haematology today.
    Jacobs P; Byrne J
    SA Nurs J; 1978 Feb; 45(2):20-2. PubMed ID: 349721
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bone marrow transplantation].
    Speck B; Gratwohl A; Tichelli A; Nissen C
    Schweiz Med Wochenschr; 1995 Aug; 125(33):1515-32. PubMed ID: 7676241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation in 65 patients with severe aplastic anemia.
    Gluckman E; Devergie A; Gerotta I; Hors J; Sasportes M; Boiron M; Bernard J
    Bull Cancer; 1981; 68(1):74-7. PubMed ID: 7013871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone marrow transplantation in malignant proliferative hematologic diseases].
    Adamczyk MB; Rupniewska ZM
    Pol Tyg Lek; 1984 Feb; 39(7):229-32. PubMed ID: 6379621
    [No Abstract]   [Full Text] [Related]  

  • 26. The association of cytotoxic antidonor HLA antibodies and mismatched marrow graft rejection.
    Ting A; Pun A; Atkinson K; Dodds A; Biggs J
    Transplant Proc; 1986 Apr; 18(2):264-6. PubMed ID: 3515662
    [No Abstract]   [Full Text] [Related]  

  • 27. Allogeneic bone marrow transplantation with non-T-cell-depleted marrow from two HLA-antigen-mismatched related donors.
    Ogawa H; Ikegame K; Kawakami M; Taniguchi Y; Oka Y; Kawase I
    Haematologica; 2004 Mar; 89(3):373-5. PubMed ID: 15020286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation.
    Grandage VL; Cornish JM; Pamphilon DH; Potter MN; Steward CG; Oakhill A; Marks DI
    Bone Marrow Transplant; 1998 Apr; 21(7):687-90. PubMed ID: 9578308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.
    Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Seo EJ; Park CJ; Chi HS; Lee JS
    Bone Marrow Transplant; 2003 Oct; 32(8):835-42. PubMed ID: 14520431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hematologic resuscitation. II. Correction of severe leukocyte and immune globulin disorders. The bone marrow graft].
    Schwarzenberg L; Cattan A; Schneider M; Schlumberger JR; Amiel JL; Mathé G
    Presse Med (1893); 1966 Apr; 74(21):1061-5. PubMed ID: 5325498
    [No Abstract]   [Full Text] [Related]  

  • 32. [What's new in pediatric hematology? (author's transl)].
    Schaison G
    Ann Pediatr (Paris); 1982 Apr; 29(4):296-300. PubMed ID: 7046599
    [No Abstract]   [Full Text] [Related]  

  • 33. Bone marrow transplantation for acute leukemia.
    Buckner CD
    Bull Cancer; 1981; 68(1):71-3. PubMed ID: 7013870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation in Canada.
    Buskard NA
    Can Med Assoc J; 1980 Jul; 123(1):19-22. PubMed ID: 6998551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous bone marrow mixed with HLA-haploidentical allogeneic marrow transplantation for treatment of patients with malignant blood diseases.
    Da WM; Liu Y; Zhong JT; Bai H; Ji MJ; Wang CB; Lu JZ; Chen JM; Wang YL; Wu XX; Xu SF; Zhang Q; Wei YM
    Bone Marrow Transplant; 1997 Jan; 19(2):107-12. PubMed ID: 9116606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of survival times in a transplant study of hematologic disorders.
    Fu P; Laughlin MJ; Zhang H
    Contemp Clin Trials; 2006 Apr; 27(2):174-82. PubMed ID: 16326144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.
    Przepiorka D; Ippoliti C; Giralt S; van Beisen K; Mehra R; Deisseroth AB; Andersson B; Luna M; Cork A; Lee M
    Bone Marrow Transplant; 1994 Sep; 14(3):449-53. PubMed ID: 7994271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autologous graft of bone marrow in hematology. Development of concepts].
    Hervé P
    Ann Med Interne (Paris); 1986; 137(2):89-91. PubMed ID: 3521432
    [No Abstract]   [Full Text] [Related]  

  • 40. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.